Professor and Medical Director, MD Anderson Cancer Center
General Surgery
Dr. Henry M. Kuerer, MD
|
|
Give Review
Henry Kuerer is an expert in the field of General Surgery. He went to Mount Sinai School of Medicine. He received awards:"Regional Top Doctor", "Regents Outstanding Teacher Award" and "Fellow (FACS)". Henry Kuerer is a published doctor and has 100 publications published. The lastest was: 'Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study.' He accepts all Medicare patients.
Publications
- Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurre...
- Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study.
- Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.
- Ductal Carcinoma In Situ: Treatment Update and Current Trends.
- Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
- Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal Carcinoma in situ in 691 patients.
- Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for Breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
- RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation.
- Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer: A Prospective Feasibility Trial.
- Sorting out the Survival Impact of Radiation Therapy in Early-Stage Invasive Breast Cancer.
- Innate immune function after Breast, lung, and colorectal cancer surgery.
- Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of Breast cancer.
- Circulating tumor cells in non-metastatic triple-negative Breast cancer.
- Management of Axillary Disease.
- Web based pathology assessment in RTOG 98-04.
- Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer.
- Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in C...
- Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing.
- Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation.
- Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment.
- Breast conservation therapy after neoadjuvant chemotherapy: Optimization of a multimodality approach.
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory Breast cancer.
- Which threshold for ER positivity? A retrospective study based on 9639 patients.
- Incidence and consequence of close margins in patients with ductal Carcinoma-in situ treated with mastectomy: is further therapy warranted?
- Feasibility of confocal fluorescence microscopy for real-time evaluation of neoplasia in fresh human Breast tissue.
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive Breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
- Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy.
- Improving Cancer care through quality measures: putting evidence to work with the COC.
- Clinical Course of Breast Cancer Patients with Isolated Sternal and Full-Thickness Chest Wall Recurrences Treated With and Without Radical Surgery.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable Breast cancer.
- Impact of chemotherapy sequencing on local-regional failure risk in Breast cancer patients undergoing Breast-conserving therapy.
- Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival.
- Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy.
- Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population.
- Biology, treatment, and outcome in very young and older women with DCIS.
- Tumor bed control with balloon-based accelerated partial Breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast ...
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns.
- The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer.
- Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the Breast.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Circulating tumour cells in non-metastatic Breast cancer: a prospective study.
- Invasive lobular carcinoma predicts micrometastasis in Breast cancer.
- Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision.
- Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in Breast cancer patients with a positive sentinel l...
- Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current...
- Reply: hiccough.
- Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer.
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive Breast cancer.
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy.
- Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group.
- Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation.
- Management of local-regional recurrence following immediate Breast reconstruction in patients with early Breast cancer treated without postmastectomy radiotherapy.
- Delays in Primary Surgical Treatment Are Not Associated with Significant Tumor Size Progression in Breast Cancer Patients.
- Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death.
- Impact of progression during neoadjuvant chemotherapy on surgical management of Breast cancer.
- Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
- Classification of ipsilateral Breast tumor recurrences after Breast conservation therapy can predict patient prognosis and facilitate treatment planning.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients with Locally Advanced Breast Cancer Requiring Postmastectomy Radiat...
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the Breast.
- Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial Breast irradiation registry trial.
- Disseminated tumor cells in biologic subtypes of stage I-III Breast cancer patients.
- Reply to Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positi...
- Higher parity and shorter Breastfeeding duration: association with triple-negative phenotype of Breast cancer.
- Present-day locoregional control in patients with t1 or t2 Breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
- Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive Breast cancer patients: experience f...
- Factors affecting the decision of Breast cancer patients to undergo contralateral prophylactic mastectomy.
- Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive Breast...
- Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive Breast cancer bef...
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in Breast cancer patients.
- Predictors of tumor progression during neoadjuvant chemotherapy in Breast cancer.
- Prospective randomized trial of paravertebral block for patients undergoing Breast cancer surgery.
- False negative rate of sentinel lymph node biopsy in multicentric and multifocal Breast cancers may be higher in cases with large additive tumor burden.
- Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in Breast cancer patients.
- Improved postoperative pain control using thoracic paravertebral block for Breast operations.
- Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
- Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
- A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lym...
- Predictors of contralateral Breast cancer in patients with unilateral Breast cancer undergoing contralateral prophylactic mastectomy.
- Ductal Carcinoma in situ: state of the science and roadmap to advance the field.
- Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage Breast cancer pa...
- Hormone receptor status and pathologic response of HER2-positive Breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
- A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects.
- Timing of Chemotherapy after MammoSite radiation therapy system Breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite Breast brachytherap...
- Road map for maintaining career satisfaction and balance in surgical oncology.
- Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive Breast cancer.
- How many sentinel lymph nodes are enough during sentinel lymph node dissection for Breast cancer?
- Timing of surgical intervention for the intact primary in stage IV Breast cancer patients.
- Mammography before diagnosis among women age 80 years and older with Breast cancer.
- The molecular journey from ductal carcinoma in situ to invasive Breast cancer.
- Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients ...
- Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
- Practical guidelines for repair of partial mastectomy defects using the Breast reduction technique in patients undergoing Breast conservation therapy.
- Current treatment and clinical trial developments for ductal carcinoma in situ of the Breast.
- Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology.
- DCIS of the Breast: a look towards discovery and advancements in the field.
- Breast ductal secretions: clinical features, potential uses, and possible applications.
- Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after Lumpectomy.
Schools
SUNY Dwnstate M C Coll Med
Mt Sinai School Med
MD Anderson Canc Center
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Atelectasis
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Regents Outstanding Teacher Award
- Fellow (FACS)
Education
-
Mount Sinai School of Medicine -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1063504090 | |
| NPPES Provider LastName | KUERER | |
| NPPES Provider FirstName | HENRY | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 49.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 32.65 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063504090 |
| Last Name Of The Provider | KUERER |
| First Name Of The Provider | HENRY |
| View All |
Similar Doctors
|
|
Dr. Michael P. Coselli, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jose V. Iglesias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Badgwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ervin Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacfranz J. Guiteau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle J. Moller, MD |
|
|
Dr. Weiyuan Mai, MD |
|
|
Dr. Olubunmi T. Ogunleye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonja E. Singletary, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Khoa D. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward R. Teitel, MD |